Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BIIB021 in Refractory GIST
NCT00618319Phase 2Completed
- Sponsor
- Biogen
- Start
- Feb 2008
- Primary completion
- Apr 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of biib021 in gastrointestinal stromal tumor (GIST), sponsored by Biogen. Started Feb 2008; status: completed.
02
Drugs
biib021
03
Conditions
gastrointestinal stromal tumor (GIST)
Beyond the preview
Go deeper on NCT00618319.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00618319.